West Nile Virus (WNV) poses a significant threat to horses nationwide because it is carried throughout the country by infected birds during migration. Mosquitoes become infected after feeding on infected birds, and can then transmit the virus to horses. Vaccination remains the most effective way to help protect horses against WNV. Equine West Nile Virus vaccine For use in healthy horses and foals 4 months of age and older May be administered to pregnant mares Killed virus vaccine, no mixing required
Vetera® WNV is for the vaccination of healthy horses and foals 4 months of age or older as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by WNV. This equine vaccine contains a killed virus and does not require reconstitution prior to administration. Vetera® WNV provides at least 12 months of protection against WNV. In addition, this high quality vaccine may be administered to pregnant mares.
Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
Precautions: Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.